Aptahem AB (APTA)

Currency in SEK
1.1500
-0.0750(-6.12%)
Closed·
APTA Scorecard
Full Analysis
Not profitable over the last twelve months
APTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.15001.3400
52 wk Range
0.56004.2298
Key Statistics
Bid/Ask
1.15 / 1.17
Prev. Close
1.225
Open
1.18
Day's Range
1.15-1.34
52 wk Range
0.56-4.2298
Volume
61.88K
Average Volume (3m)
56.03K
1-Year Change
-59.08%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
APTA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Price has performed poorly over the last decade

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Aptahem AB Company Profile

Aptahem AB (publ), a biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. The company’s lead products candidate is Apta-1, which is in preclinical stage to prevent the onset of life-threatening organ and tissue damage in sepsis patients. It has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children’s Research Institute, and University Health Network. Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.

Compare APTA to Peers and Sector

Metrics to compare
APTA
Peers
Sector
Relationship
P/E Ratio
−2.5x−9.7x−0.5x
PEG Ratio
−0.03−0.200.00
Price/Book
0.3x6.8x2.6x
Price / LTM Sales
6.0x42.9x3.2x
Upside (Analyst Target)
-6.8%41.4%
Fair Value Upside
Unlock4.2%6.0%Unlock

Earnings

Latest Release
May 22, 2025
EPS / Forecast
-0.17 / --
Revenue / Forecast
617.00K / --
EPS Revisions
Last 90 days

APTA Income Statement

FAQ

What Stock Exchange Does Aptahem AB Trade On?

Aptahem AB is listed and trades on the Spotlight Stock Market stock exchange.

What Is the Stock Symbol for Aptahem AB?

The stock symbol for Aptahem AB is "APTA."

What Is the Aptahem AB Market Cap?

As of today, Aptahem AB market cap is 19.85M.

What Is Aptahem AB's Earnings Per Share (TTM)?

The Aptahem AB EPS (TTM) is -0.55.

From a Technical Analysis Perspective, Is APTA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Aptahem AB Stock Split?

Aptahem AB has split 3 times.

How Many Employees Does Aptahem AB Have?

Aptahem AB has 8 employees.

What is the current trading status of Aptahem AB (APTA)?

As of 27 Jul 2025, Aptahem AB (APTA) is trading at a price of 1.15, with a previous close of 1.23. The stock has fluctuated within a day range of 1.15 to 1.34, while its 52-week range spans from 0.56 to 4.23.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.